PubMed

Medication diaries do not improve outcomes with highly active antiretroviral therapy in Kenyan children: a randomized clinical trial.

Wamalwa DC, Farquhar C, Obimbo EM, Selig S, Mbori-Ngacha DA, Richardson BA, Overbaugh J, Egondi T, Inwani I, John-Stewart G.

J Int AIDS Soc. 2009 Jun 24;12(1):8.PMID: 19549342 [PubMed - in process]Related articlesFree article

Early response to highly active antiretroviral therapy in HIV-1-infected Kenyan children.

Wamalwa DC, Farquhar C, Obimbo EM, Selig S, Mbori-Ngacha DA, Richardson BA, Overbaugh J, Emery S, Wariua G, Gichuhi C, Bosire R, John-Stewart G.

J Acquir Immune Defic Syndr. 2007 Jul 1;45(3):311-7.PMID: 17356470 [PubMed - indexed for MEDLINE]Related articles

Impact on weight and height with the use of HAART in HIV-infected children.

Guillén S, Ramos JT, Resino R, Bellón JM, Muñoz MA.

Pediatr Infect Dis J. 2007 Apr;26(4):334-8.PMID: 17414398 [PubMed - indexed for MEDLINE]Related articles

Efficacy of first-line, WHO recommended generic HAART regimens in Indian children.

Parakh A, Dubey AP, Kumar A, Maheshwari A, Saxena R.

Kathmandu Univ Med J (KUMJ). 2009 Jul-Sep;7(27):220-5.PMID: 20071866 [PubMed - in process]Related articles

Adherence to antiretroviral therapy in young children in Cape Town, South Africa, measured by medication return and caregiver self-report: a prospective cohort study.

Davies MA, Boulle A, Fakir T, Nuttall J, Eley B.

BMC Pediatr. 2008 Sep 4;8:34.PMID: 18771599 [PubMed - indexed for MEDLINE]Related articlesFree article

Pattern and predictors of immunologic recovery in human immunodeficiency virus-infected children receiving non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy.

Puthanakit T, Kerr S, Ananworanich J, Bunupuradah T, Boonrak P, Sirisanthana V.

Pediatr Infect Dis J. 2009 Jun;28(6):488-92.PMID: 19504731 [PubMed - indexed for MEDLINE]Related articles

Efficacy of non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy in Thai HIV-infected children aged two years or less.

Puthanakit T, Aurpibul L, Sirisanthana T, Sirisanthana V.

Pediatr Infect Dis J. 2009 Mar;28(3):246-8.PMID: 19165130 [PubMed - indexed for MEDLINE]Related articles

Impact of HAART on survival, weight gain and resting energy expenditure in HIV-1-infected children in India.

Banerjee T, Pensi T, Banerjee D, Grover G.

Ann Trop Paediatr. 2010;30(1):27-37.PMID: 20196931 [PubMed - in process]Related articles

Modifications of HIV-1 DNA and provirus-infected cells during 24 months of intermittent highly active antiretroviral therapy.

Palmisano L, Giuliano M, Chiarotti F, Zanchetta M, Andreotti M, Pirillo MF, Riva E, Antonelli G, De Rossi A, Vella S.

J Acquir Immune Defic Syndr. 2008 May 1;48(1):68-71.PMID: 18360287 [PubMed - indexed for MEDLINE]Related articles

Providing patients with information about disease-modifying anti-rheumatic drugs: Individually or in groups? A pilot randomized controlled trial comparing adherence and satisfaction.

Homer D, Nightingale P, Jobanputra P.

Musculoskeletal Care. 2009 Jun;7(2):78-92.PMID: 18792423 [PubMed - indexed for MEDLINE]Related articles

Five-year follow-up of children with perinatal HIV-1 infection receiving early highly active antiretroviral therapy.

Chiappini E, Galli L, Tovo PA, Gabiano C, Lisi C, Bernardi S, Viganò A, Guarino A, Giaquinto C, Esposito S, Badolato R, Di Bari C, Rosso R, Genovese O, Masi M, Mazza A, de Martino M.

BMC Infect Dis. 2009 Aug 26;9:140.PMID: 19709432 [PubMed - indexed for MEDLINE]Related articlesFree article

A feasibility study of immediate versus deferred antiretroviral therapy in children with HIV infection.

Ananworanich J, Kosalaraksa P, Siangphoe U, Engchanil C, Pancharoen C, Lumbiganon P, Intasan J, Apateerapong W, Chuenyam T, Ubolyam S, Bunupuradah T, Lange J, Cooper DA, Phanuphak P; HIV-NAT 010 Study Team.

AIDS Res Ther. 2008 Oct 28;5:24.PMID: 18957095 [PubMed]Related articlesFree article

[Highly active antiretroviral therapy in HIV sero-positive children. Disease progression by baseline clinical, immunological and virological status]

Rodríguez de Schiavi MS, Scrigni A, García Arrigoni P, Bologna R, Barboni G, Redondo J, Nastri M, Mecikovsky D, Cantisano C, Moreno R, Siciliani D, Lencina M, Luedicke N, Rezzónico G, Torolla JL, López Papucci S, Luis M, Libonati C, Gamba L, Barbarysky J, Pérez Hernández E, Zlatkes R.

Arch Argent Pediatr. 2009 Jun;107(3):212-20. Spanish. PMID: 19543629 [PubMed - indexed for MEDLINE]Related articlesFree article

Modifications of residual viraemia in human immunodeficiency virus-1-infected subjects undergoing repeated highly active antiretroviral therapy interruptions.

Palmisano L, Giuliano M, Bucciardini R, Andreotti M, Fragola V, Pirillo MF, Weimer LE, Mancini MG, Vella S.

J Med Microbiol. 2009 Jan;58(Pt 1):121-4.PMID: 19074663 [PubMed - indexed for MEDLINE]Related articlesFree article

Prevention of mother-to-child transmission of HIV-1 through breastfeeding by treating mothers with triple antiretroviral therapy in Dar es Salaam, Tanzania: the Mitra Plus study.

Kilewo C, Karlsson K, Ngarina M, Massawe A, Lyamuya E, Swai A, Lipyoga R, Mhalu F, Biberfeld G; Mitra Plus Study Team.

J Acquir Immune Defic Syndr. 2009 Nov 1;52(3):406-16.PMID: 19730269 [PubMed - indexed for MEDLINE]Related articles

The Influence of Nutritional Status on the Response to HAART in HIV-Infected Children in South Africa.

Naidoo R, Rennert W, Lung A, Naidoo K, McKerrow N.

Pediatr Infect Dis J. 2010 Feb 18. [Epub ahead of print]PMID: 20179664 [PubMed - as supplied by publisher]Related articles

Response to antiretroviral therapy in HIV-infected Ugandan children exposed and not exposed to single-dose nevirapine at birth.

Musoke PM, Barlow-Mosha L, Bagenda D, Mudiope P, Mubiru M, Ajuna P, Tumwine JK, Fowler MG.

J Acquir Immune Defic Syndr. 2009 Dec;52(5):560-8.PMID: 19950430 [PubMed - indexed for MEDLINE]Related articles

Poor Efficacy and Tolerability of Stavudine, Didanosine, and Efavirenz-based Regimen in Treatment-Naive Patients in Senegal.

Canestri A, Sow PS, Vray M, Ngom F, M'boup S, Kane CT, Delaporte E, Gueye M, Peytavin G, Girard PM, Landman R; the ANRS 12–06/IMEA 012 Trial Study Group.

J Int AIDS Soc. 2007 Oct 9;9(4):7.PMID: 19825141 [PubMed - as supplied by publisher]Related articlesFree article

Antiretroviral treatment outcome following genotyping in Thai children who failed dual nucleoside reverse transcriptase inhibitors.

Bunupuradah T, Suntarattiwong P, Li A, Sirivichayakul S, Pancharoen C, Boonrak P, Puthanakit T, Kerr SJ, Ruxrungtham K, Chotpitayasunondh T, Hirschel B, Ananworanich J; the HIV-NAT 013 Study Team.

Int J Infect Dis. 2009 Aug 20. [Epub ahead of print]PMID: 19699673 [PubMed - as supplied by publisher]Related articles

Clinical manifestations of adolescents with HIV/AIDS in Jamaica.

Harrison A, Pierre RB, Palmer P, Moore J, Davis D, Dunkley-Thompson J, Figueroa JP, Christie CD.

West Indian Med J. 2008 Jun;57(3):257-64.PMID: 19583125 [PubMed - in process]Related articles